MedTrace Logo

International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project

NCT05387811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1456

Last updated 2024-01-30

No results posted yet for this study

Summary

The aims of this study will be to identify the clinical characteristics, the management and the outcomes of acute kidney injury in patients with cirrhosis worldwide.

Specific aims:

1. To establish the severity of AKI across different regions
2. To identify precipitants of AKI across different centers
3. To identify the phenotypes of AKI across different centers
4. To evaluate differences in the management of AKI across different centers and their impact on clinical outcomes
5. To assess outcomes of acute kidney injury (resolution of AKI, in-hospital mortality, 28-day mortality, 90-day mortality)

Conditions

Interventions

COMBINATION_PRODUCT

Crystalloids, albumin, vasoconstrictors, diuretics, renal replacement therapy

Adherence to International Club of Ascites recommendations for the management of AKI

Sponsors & Collaborators

  • Azienda Ospedaliera di Padova

    lead OTHER

Principal Investigators

  • Salvatore Piano, MD · Azienda Ospedaliera di Padova

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2023-09-30
Completion
2023-11-30

Countries

  • United States
  • Argentina
  • Brazil
  • Chile
  • China
  • Denmark
  • Egypt
  • Ethiopia
  • France
  • Germany
  • Hungary
  • India
  • Italy
  • Mexico
  • Netherlands
  • Paraguay
  • Peru
  • Poland
  • Russia
  • South Korea
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05387811 on ClinicalTrials.gov